KEQU icon

Kewaunee Scientific

45.25 USD
-0.52
1.14%
At close Updated Sep 17, 4:00 PM EDT
1 day
-1.14%
5 days
-3.78%
1 month
-20.47%
3 months
23.03%
6 months
-11.36%
Year to date
-27.8%
1 year
20.92%
5 years
396.71%
10 years
172.92%
 

About: Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

Employees: 1,239

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

41% more capital invested

Capital invested by funds: $46M [Q1] → $64.9M (+$18.9M) [Q2]

2.21% less ownership

Funds ownership: 41.0% [Q1] → 38.79% (-2.21%) [Q2]

17% less funds holding

Funds holding: 42 [Q1] → 35 (-7) [Q2]

36% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 14

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Financial journalist opinion

Based on 5 articles about KEQU published over the past 30 days

Neutral
Zacks Investment Research
5 days ago
Kewaunee Scientific Q1 Earnings Rise Y/Y, Stock Slides 19%
KEQU's Q1 revenues and EPS grow y/y, aided by Nu Aire, yet shares drop 19% as investors weigh uneven project timelines and rising costs.
Kewaunee Scientific Q1 Earnings Rise Y/Y, Stock Slides 19%
Neutral
PRNewsWire
6 days ago
Kewaunee Scientific Announces Appointment of J. Jette Campbell to Board of Directors
STATESVILLE, N.C. , Sept. 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, announces the appointment of J.
Kewaunee Scientific Announces Appointment of J. Jette Campbell to Board of Directors
Neutral
PRNewsWire
7 days ago
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026
STATESVILLE, N.C. , Sept. 10, 2025 /PRNewswire/ -- PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2025.
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026
Neutral
PRNewsWire
15 days ago
Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai
STATESVILLE, N.C. , Sept. 2, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2025 Arablab Live tradeshow and conference, taking place in Dubai from September 23-25.
Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai
Neutral
PRNewsWire
21 days ago
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026
STATESVILLE, N.C. , Aug. 27, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2026 financial results on Wednesday, September 10, 2025 after the close of trading.
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026
Positive
Zacks Investment Research
1 month ago
Kewaunee Upgraded to Outperform on Nu Aire Synergies, Backlog
KEQU earns an upgrade to "Outperform" as Nu Aire integration drives sales growth, margins expand and a record backlog boosts visibility, offsetting tariff risks with proactive inventory strategies.
Kewaunee Upgraded to Outperform on Nu Aire Synergies, Backlog
Positive
Zacks Investment Research
2 months ago
Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates
KEQU posts strong Q4 and FY25 results, driving a 47% stock surge as sales jump and the Nu Aire acquisition boosts growth momentum.
Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates
Positive
Seeking Alpha
2 months ago
Kewaunee Scientific: Huge Improvement In Operational Outlook (Upgrade To Buy)
Kewaunee Scientific's strong FY2025 results, record backlog, and margin expansion signal a return to growth and improved business predictability. Adjusted EPS actually rose 28% year-over-year, once non-recurring items and acquisition costs are excluded, reflecting core operational strength. A 38% increase in backlog suggests robust revenue growth for FY2026, supporting a bullish outlook and more potential stock upside.
Kewaunee Scientific: Huge Improvement In Operational Outlook (Upgrade To Buy)
Neutral
PRNewsWire
2 months ago
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
STATESVILLE, N.C. , June 25, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025.
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
Neutral
PRNewsWire
3 months ago
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
STATESVILLE, N.C. , June 11, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2025 on Wednesday, June 25, 2025 after the close of trading.
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
Charts implemented using Lightweight Charts™